Aug 06, 2020 (Market Insight Reports) -- Selbyville, Delaware MarketStudyReport.com Adds New Insulin Delivery Devices Market 2018 - 2025 research report providing information and data By Product, End User, Industry Analysis, Regional Outlook, Growth Potential, Competitive Market Share & Forecast spreading across 194 Pages with table and figures in it.
The growth of the insulin delivery devices market is primarily attributed to the rise in obesity and increasing technological advancement in insulin delivery devices are the major factors that are anticipated to propel the growth for the insulin delivery devices market. However, complications and risk associated with the delivery of insulin expected to act as major challenges hindering the market growth. On the other hand, growing product innovations is expected to be prevalent future trend in the global insulin delivery devices market
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/2095852/?utm_source=Marketwatch.com&utm_medium=AN
The global insulin delivery devices market is expected to reach US$ 22,830.0 Mn by 2025 from US$ 11,869.0 Mn in 2017. The market is estimated to grow with a CAGR of 8.7% during the forecast period from 2018 to 2025. Global insulin delivery devices market, based on the product was segmented into insulin pens, insulin pumps, insulin syringes, pen needles and others. The insulin pens segment is further segmented into reusable insulin pens and disposable insulin pens segments. The insulin pumps segment is also further bifurcated into tube pumps and patch pumps. Based on pen needle segment, the market is further segmented into standard pen needles and safety pen needles. In 2017, the insulin pens segment held the largest market share among the product segment. This is primarily attributed to its ease of use and its increasing recommendation for its use by the healthcare providers as well as its ease of use, and lesser side effects. The insulin pumps segment is also expected to grow at the fastest rate during the coming years.
The global market of insulin delivery devices was classified into patients/homecare and hospitals & clinics segments, by the end user. The patients/homecare segment anticipated to the largest and fastest growing segment in the forecast period. The increasing diabetic population and increasing adoption of the insulin delivery devices are majorly helping in the growth of this market. Moreover, the ease of use, availability, and accessibility of insulin delivery devices has also increased the adoption of self-administration among patients that proportionally upsurge the rate of using insulin delivery devices in patients or homecare settings.
The insulin delivery devices market was estimated through extensive primary and secondary sources that included a vast array of government authorized websites such as Chinese Diabetes Society (CDS), Food and Drug Administration (FDA), International Diabetes Federation (IDF), National Health Service (NHS), National Institute for Health and Care Excellence (NICE) and others. The primary respondents included chair-holders and representatives of the demand and supply side for healthcare industries as well as medical professionals at various insulin delivery device manufacturing companies, hospitals, and research centers.
Table of content:
1.1 SCOPE OF THE STUDY 25
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 25
GLOBAL INSULIN DELIVERY DEVICES MARKET – KEY TAKEAWAYS 26
GLOBAL INSULIN DELIVERY DEVICES MARKET – MARKET LANDSCAPE 28
3.1 OVERVIEW 28
3.2 MARKET SEGMENTATION 28
3.2.1 Insulin Delivery Devices Market – By Product 29
3.2.2 Insulin Delivery Devices Market – By End User 30
3.2.3 Insulin Delivery Devices Market – By Geography 30
3.3 PEST ANALYSIS 31
3.3.1 North America – PEST Analysis 31
3.3.2 Europe – PEST Analysis 34
3.3.3 Asia Pacific – PEST Analysis 36
3.3.4 Middle East & Africa – PEST Analysis 39
3.3.5 South & Central America – PEST Analysis 41
GLOBAL INSULIN DELIVERY DEVICES MARKET – KEY MARKET DYNAMICS 43
4.1 KEY MARKET DRIVERS 43
4.1.1 Increasing Prevalence of Diabetes 43
4.1.2 Rapid Growth in the Geriatric Population 44
4.1.3 Rise in Obesity Associated with Increasing Sedentary Lifestyle and Improper Diet 45
4.1.4 Increasing Technological Advancement in Insulin Delivery Devices 46
4.2 KEY MARKET RESTRAINTS 47